Midatech Pharma Plcの評価平均
Midatech Pharma Plcの評価平均は何ですか。
Midatech Pharma Plcの評価平均は3.00です。
評価平均の定義は何ですか。
Recommendation meanは、株式のアナリストの格付けの平均値で、1.0（強い買い）から5.0（強い売り）の範囲です。
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
LSEのセクタHealth Careにおける評価平均の企業と比べるMidatech Pharma Plc
Midatech Pharma Plcは何をしますか。
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Midatech Pharma Plcと類似の評価平均
- Callon Petroleum Coの評価平均は2.94です。
- Park Hotels & Resorts Incの評価平均は2.94です。
- Hexcelの評価平均は2.95です。
- Aegonの評価平均は2.95です。
- Intelの評価平均は2.95です。
- MGM Resorts Internationalの評価平均は2.95です。
- Midatech Pharma Plcの評価平均は3.00です。
- Continental Resources Inc (OKLA)の評価平均は3.03です。
- Albemarleの評価平均は3.04です。
- Cognexの評価平均は3.05です。
- Ventas Incの評価平均は3.05です。
- Texas Capital Bancsharesの評価平均は3.07です。
- Pebblebrook Hotel Trustの評価平均は3.07です。